MannKind Corporation
NASDAQMannKind Corporation heads into its May 8 Q1 earnings call with call buyers firmly in charge — and a stock that has just retraced nearly half of a devastating post-earnings collapse in under six weeks. The options market is the clearest tell. The put/call ratio has dropped to 0.35, well below its 20-day average of 0.40 and nearly 1.3 standard deviations below that mean — the most…
Snapshot as of 7 May 2026
MannKind Corporation heads into its May 8 Q1 earnings call with call buyers firmly in charge — and a stock that has just retraced nearly half of a devastating post-earnings collapse in under six weeks. The options…
MNKD reports Q1 2026 results on the same day it announced a new dry powder inhalation program for Ralinepag — a partnership with United Therapeutics — giving the stock two live catalysts to absorb at once. The options…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MNKD — free to start on ORTEX.
Sign up for free →Open MNKD on ORTEX